Summary
ADVANCED BIOSCIENCE LABORATORIES has no OSHA inspection history on file. Federal records covering wage, environmental, labor relations, and other agencies are noted below where present.
The most recent federal enforcement activity was recorded 0 days ago.
Federal records were found in 1 of 15 sources. Sources without matching records returned empty for this establishment.
Agency coverage
ADVANCED BIOSCIENCE LABORATORIES appears in CPSC product recalls record only. No matching records were found in OSHA workplace safety, WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, OFLC visa and labor certification, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, or NHTSA vehicle recalls. Single-agency enforcement records typically indicate either a discrete incident-based inspection or a low-risk operational profile.
OSHA workplace safety
No OSHA inspections, citations, or accidents on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with Occupational Safety and Health Administration →
Safety self-report (OSHA 300A)
No self-reported injury rates filed with OSHA's Injury Tracking Application for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with OSHA Injury Tracking Application →
OSHA severe injury reports
No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with Occupational Safety and Health Administration →
Activity timeline
Most recent federal enforcement activity recorded 0 days ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
No WHD wage, overtime, or child-labor enforcement cases on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with Wage and Hour Division →
Mine safety (MSHA)
No MSHA mine safety violations on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC)
No H-1B, H-2A, or H-2B labor condition applications on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with Office of Foreign Labor Certification →
Environmental compliance (EPA)
No EPA inspections or formal enforcement actions on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with Environmental Protection Agency →
Federal criminal prosecution record
No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for ADVANCED BIOSCIENCE LABORATORIES. Verify directly with UVA Corporate Prosecution Registry →
CPSC product recalls
Top hazard: The brake component housed within the bicycle's carbon fork can disengage from the fork and allow the brake assembly to contact the wheel spokes while rotating, posing a fall hazard.. Most recent recall: 2011-09-22. Source: Consumer Product Safety Commission, matched on company name.
Federal contracts
This location
Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.
- Department of Health and Human ServicesTHE TASK ORDER IS TO SUPPORT CGMP MANUFACTURING OF THE PGT121.414.LS MONOCLONAL ANTIBODY (PGT121.414.LS MAB) DRUG SUBSTANCE FROM AN ESTABLISHED MANUFACTURING PROCESS, COMPLETE THE FILL FINISH OF THE DRUG SUBSTANCE (DS) INTO DRUG PRODUCT (DP), QUALITYcontract · Last action 2025-09-30$17,241,407
- Department of Health and Human ServicesCOMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTIONcontract · Last action 2021-08-02$15,342,949
- Department of Health and Human ServicesIGF::OT::IGF SIMIAN VACCINE EVALUATION UNITScontract · Last action 2024-06-18$15,116,116
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIEScontract · Last action 2026-03-30$12,942,880
- Department of Health and Human ServicesAI-00021I - ADVANCED BIOSCIENCE LABORATORIES, INC. - DAIDS CAN# 8470035 - $1,996,916contract · Last action 2021-07-15$12,201,594
- Department of Health and Human ServicesIGF::OT::IGF - NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF THE MHRP GP145 CLADE C TRIMER PROTEINcontract · Last action 2025-06-06$9,967,500
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1 GP120 PROTEINcontract · Last action 2023-07-26$9,821,226
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEINcontract · Last action 2025-07-30$9,545,732
- Department of Health and Human ServicesCGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAINcontract · Last action 2025-05-29$9,340,093
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHO CELL BANK FOR USE IN TRANSIENT TRANSFECTIONcontract · Last action 2020-04-27$9,260,093
- Department of Health and Human ServicesIGF::OT::IGF ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORTcontract · Last action 2024-09-12$9,085,963
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEINcontract · Last action 2022-11-17$7,926,447
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALScontract · Last action 2025-04-11$7,712,780
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT: PRODUCTION OF ALVAC-HIV DRUG PRODUCT AND DILUENTcontract · Last action 2023-01-26$6,846,036
- Department of Health and Human ServicesTHIS TASK ORDER IS FOR (A) DOWNSTREAM ENGINEERING RUN PRODUCTION, (B) DOWNSTREAM CURRENT GOOD MANUFACTURING PRACTICES MANUFACTURING PRODUCTION (CGMP), (C) FILL/FINISH & LABELING, (D) ANALYTICAL DEVELOPMENT/RELEASE (E) ACCELERATED STABILITY TESTINcontract · Last action 2024-05-29$6,721,455
- Department of Health and Human ServicesIGF::OT::IGF NONHUMAN PRIMATE PURCHASE AND HOLDINGcontract · Last action 2025-06-17$6,580,683
- Department of Health and Human ServicesNONHUMAN PRIMATE CORE QUANTITATIVE VIRAL RNA LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTcontract · Last action 2020-07-23$4,857,613
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINScontract · Last action 2022-04-04$4,709,463
- Department of Health and Human ServicesCGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINEcontract · Last action 2025-09-22$4,683,305
- Department of Health and Human ServicesIGF::OT::IGF - R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)contract · Last action 2024-12-12$4,612,477
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINEcontract · Last action 2024-12-19$4,447,235
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1GP120 PROTEINcontract · Last action 2025-07-30$4,240,925
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1 GP120 PROTEINcontract · Last action 2017-08-01$4,056,422
- Department of Health and Human ServicesAWARD OF TASK ORDER #2 (MANUFACTURE OF A VACCINE TARGETING FRAME-SHIFT MUTATIONS CHARACTERISTIC OF TUMORS WITH MICROSATELLITE INSTABILITY) UNDER CONTRACT 75N91019D00025 CURRENT POP: 9/19/19-7/18/20. IF OPTIONS EXERCISED, POP MAY BE EXTENDED THROUGH 3contract · Last action 2024-03-27$3,873,113
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENVELOPE TRIMER PROTEINScontract · Last action 2021-09-21$3,816,780
- Department of Health and Human ServicesFEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA.contract · Last action 2026-02-25$3,782,538
- Department of Health and Human ServicesABL MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASEScontract · Last action 2026-04-02$3,752,675
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140contract · Last action 2025-06-26$3,731,476
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALScontract · Last action 2020-07-22$3,649,061
- Department of Health and Human ServicesIGF::OT::IGF SIMIAN VACCINE EVALUATION UNITScontract · Last action 2024-06-18$3,605,431
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1 M GROUP CONSERVED ELEMENT DNAScontract · Last action 2023-06-23$3,190,957
- Department of Health and Human ServicesIGF::OT::IGF FILL-FINISH, RELEASE, AND STABILITY TESTING OF HIV-1 GP120 PROTEINS $2,302,002 ON CAN 17-8470035.contract · Last action 2025-06-26$3,017,609
- Department of Health and Human ServicesMANUFACTURE AND CHARACTERIZAITON SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES CHOLERA INABA OSP-CORE-TETANUS TOXIN HEAVY CHAIN VACCINE PDcontract · Last action 2017-06-26$3,015,314
- Department of Health and Human ServicesIGF::OT::IGF SUPPORT FOR RESEARCH ON RETROVIRAL PATHOGENESIS, TREATMENT, AND PREVENTIONcontract · Last action 2024-11-13$3,011,769
- Department of Health and Human ServicesNIAID PRECLINICAL DEVELOPMENT SUPPORT; SYNTHESIZE AND PRODUCE HIV-1 ENVELOPE GLYCPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE(S)contract · Last action 2024-09-16$2,959,434
- Department of Health and Human ServicesR&D- MEDICAL: AIDS RESEARCH (MANAGEMENT/SUPPORT)contract · Last action 2024-09-06$2,857,610
- Department of Health and Human ServicesTASK ORDER HHSN27200002contract · Last action 2016-06-14$2,841,668
- Department of Health and Human ServicesIGF::OT::IGF SIMIAN VACCINE EVALUATION UNITScontract · Last action 2024-09-25$2,833,961
- Department of Health and Human ServicesIGF::OT::IGFcontract · Last action 2022-07-19$2,745,188
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORTcontract · Last action 2024-12-19$2,696,523
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEINcontract · Last action 2022-08-18$2,650,394
- Department of Health and Human ServicesEXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: BLOCKER DISCOVERYcontract · Last action 2025-09-23$2,596,609
- Department of Health and Human ServicesIGF::OT::IGF SUPPORT FOR RESEARCH ON RETROVIRAL PATHOGENESIS, TREATMENT AND PREVENTIONcontract · Last action 2023-02-23$2,403,264
- Department of Health and Human ServicesIGF::OT::IGF 1200005I ABL - VACCINE MANUFACTURING - TASK ORDER 05 BASE -contract · Last action 2023-09-21$2,324,768
- Department of Health and Human ServicesFINAL TRANSITION AND CONTINUED OPERATION OF THE NHP BREEDING COLONY DURING TRANSITIONcontract · Last action 2021-02-03$2,252,481
- Department of Health and Human ServicesIGF::OT::IGF SIMIAN VACCINE EVALUATION UNITScontract · Last action 2025-06-11$2,185,236
- Department of Health and Human ServicesCHARACTERIZATION OF THE PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) PROFILE OF A CANDIDATE HIV PREVENTION DRUG IN RHESUS MACAQUEScontract · Last action 2024-04-26$2,182,653
- Department of Health and Human ServicesQUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORTcontract · Last action 2026-03-30$2,171,969
- Department of Health and Human ServicesIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORTcontract · Last action 2023-11-06$2,152,834
- Department of Health and Human ServicesTHE CONTRACTOR SHALL SUPPORT THE ADMINISTRATIVE AND TECHNICAL ACTIVITIES CONDUCTED ON A RECURRING BASIS TO PROVIDE QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT TO TASK ORDERS AWARDED UNDER TASK AREAS A, B, C, AND D.contract · Last action 2025-07-07$2,109,777
Federal contract dollars to this establishment. Primary NAICS: 541712 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY). Last action: 2026-04-02. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.
In the news
Related searches
- Employers in MDState-wide enforcement data
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →About this data
This profile aggregates federal enforcement records on ADVANCED BIOSCIENCE LABORATORIES from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Frequently asked
- What is ADVANCED BIOSCIENCE LABORATORIES's OSHA violation history?
- ADVANCED BIOSCIENCE LABORATORIES has no OSHA inspections on record.